DEMOGRAPHIC AND SOCIOECONOMIC CHARACTERISTICS THAT IMPACT SELECTION OF ORAL ANTICOAGULANTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS

被引：1
|
作者：
Keshishian, A. [1 ]
Du, J. [1 ]
Xie, L. [1 ]
Yuce, H. [2 ,3 ]
Baser, O. [3 ,4 ]
机构：
[1] STATinMED Res, Ann Arbor, MI USA
[2] CUNY, New York City Coll Technol, New York, NY 10021 USA
[3] STATinMED Res, New York, NY USA
[4] Columbia Univ, New York, NY USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.139
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV88
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [21] Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
    Hwang, Ki Won
    Choi, Jin Hee
    Lee, Soo Yong
    Lee, Sang Hyun
    Chon, Min Ku
    Lee, Jungkuk
    Kim, Hasung
    Kim, Yong-Giun
    Choi, Hyung Oh
    Kim, Jeong Su
    Park, Yong-Hyun
    Kim, June Hong
    Chun, Kook Jin
    Nam, Gi-Byoung
    Choi, Kee-Joon
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [22] Effect of new oral anticoagulants on platelet indices in non-valvular atrial fibrillation patients
    Duzen, Irfan Veysel
    Oguz, Elif
    Cekici, Yusuf
    Yavuz, Fethi
    Vuruskan, Ertan
    Sincer, Isa
    Poyraz, Fatih
    Alici, Hayri
    Yuksek, Umit
    Demirtas, Abdullah Orhan
    Sucu, Murat
    HERZ, 2021, 46 (01) : 76 - 81
  • [23] Inappropriate dose of direct oral anticoagulants therapy in patients with non-valvular atrial fibrillation
    Ito, M.
    Kaikita, K.
    Sueta, D.
    Ishii, M.
    Oimatsu, Y.
    Mitsuse, T.
    Arima, Y.
    Iwashita, S.
    Takahashi, A.
    Kanazawa, H.
    Kaneko, S.
    Kanemaru, Y.
    Kiyama, T.
    Yamabe, H.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 485 - 486
  • [24] Renal outcomes in Asian patients receiving oral anticoagulants for non-valvular atrial fibrillation
    Shahzada, Tayyab Salim
    Guo, Cosmos L.
    Lee, Alex P. W.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (01) : 24 - 32
  • [25] Dosing of Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation and Renal Dysfunction
    Rymer, Jennifer A.
    Webb, Laura E.
    Wang, Tracy Y.
    CIRCULATION, 2021, 144
  • [26] Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
    Ki Won Hwang
    Jin Hee Choi
    Soo Yong Lee
    Sang Hyun Lee
    Min Ku Chon
    Jungkuk Lee
    Hasung Kim
    Yong-Giun Kim
    Hyung Oh Choi
    Jeong Su Kim
    Yong-Hyun Park
    June Hong Kim
    Kook Jin Chun
    Gi-Byoung Nam
    Kee-Joon Choi
    BMC Cardiovascular Disorders, 23
  • [27] Anticoagulants and the incidence of cancer among individuals with non-valvular atrial fibrillation
    Abrahami, Devin
    Renoux, Christel
    Yin, Ms. Hui
    Fournier, Jean-Pascal
    Azoulay, Laurent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 636 - 636
  • [28] CLINICAL AND DEMOGRAPHICS CHARACTERISTICS OF NON-VALVULAR ATRIAL FIBRILLATION PATIENTS SWITCHING FROM WARFARIN TO NOVEL ORAL ANTICOAGULANTS
    Kachroo, S.
    Pan, X.
    Liu, L.
    Kawabata, H.
    Phatak, H.
    VALUE IN HEALTH, 2014, 17 (07) : A500 - A501
  • [29] Impact of Renal Function on Bleeding Risk in Patients With Non-Valvular Atrial Fibrillation Treated With Direct Oral Anticoagulants
    Kobayashi, Tomoaki
    Sotomi, Yohei
    Hirata, Akio
    Hirayama, Atsushi
    Higuchi, Yoshiharu
    CIRCULATION, 2019, 140
  • [30] Adherence to oral anticoagulants in patients with non-valvular atrial fibrillation: the role of patients' characteristics and out-of-pocket payments
    Al-Obaidi, Siraj
    Hijazeen, Rima
    Arabyat, Rasha M.
    Alabbadi, Ibrahim
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (07) : 845 - 852
12345